Conservative therapy of erectile dysfunction [Konservative Therapie der erektilen Dysfunktion]

被引:0
|
作者
Trottmann M. [1 ]
Marcon J. [1 ]
Pompe S. [2 ]
Strobach D. [2 ]
Becker A.J. [1 ]
Stief C.G. [1 ]
机构
[1] Urologische Klinik und Poliklinik, Ludwig-Maximilians-Universität München, Campus Großhadern, Marchioninistr. 15, München
[2] Apotheke des Klinikums der Ludwig-Maximilians-Universität München, Campus Großhadern, München
来源
Der Urologe | 2015年 / 54卷 / 5期
关键词
Alprostadil; Erectile dysfunction; Intracavernous injection; Phosphodiesterase; 5; inhibitors; Vacuum erection devices;
D O I
10.1007/s00120-015-3794-3
中图分类号
学科分类号
摘要
The erectile dysfunction (ED) with a prevalence of 19.2 % and a steep age-related increase up to 53.4 % in men over 70 years is a common sexual disorder. Especially after market launch of the phosphodiesterase 5 inhibitors the possibility of an easy-to-use and well-tolerated therapy is available. In case of nonresponse, vasoactive substances can be applied in different forms. In case of an additional hypogonadism, testosterone substitution is indicated. Simultaneously the causes of ED should always be treated, including a change of lifestyle with elimination of exogenous noxa. The use of mechanic tools as single or combination therapy can lead to improved erection. This article provides a critical overview of the latest conservative therapy options, it explains previous unsuccessful therapeutic trials and gives an outlook into potential ED therapy concepts of the future. © 2015, Springer-Verlag Berlin Heidelberg.
引用
收藏
页码:668 / 675
页数:7
相关论文
共 50 条